BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV, TASE: BVXV) today announced that it will be closing trading on the NASDAQ market on Friday, July 10, 2015, in celebration of its recent initial public offering in the United States and the launch of its international investor relations program. This event will be the culmination of a week of meetings as part of a non-deal roadshow with US-based institutional investors and financial analysts.
In addition, BiondVax today announced the launch of its new investor relations website, which can be found at http://www.biondvax.com.
Institutional investors or analysts interested in meeting with BiondVax management in New York or wishing to attend the market closing event should contact the Company's investor relations team.
Ron Babecoff, BiondVax's President and CEO, commented, "We are very much looking forward to launching our investor relations operations in the US. The closing event at the NASDAQ is an excellent starting point and the culmination of a long and an important process for us, of listing our shares in the United States, and by that making ourselves accessible to the US capital market."
New modular strategy reduces piperidine synthesis steps for pharmaceuticals